Across TCGA pan-cancer cohorts, TLE7 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of TLE7’s most consistent transcriptional readouts.
The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where TLE7 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types TLE7 is over-expressed in tumor.
KIRP and LUAD are the cancer types where TLE7 tumor–normal differential expression is most reproducible.